What is the medication classification of selegiline?
•
4 min read
First approved by the FDA in 1989 for treating Parkinson's disease, selegiline's primary classification is as a monoamine oxidase inhibitor, specifically a selective and irreversible inhibitor of the MAO-B enzyme at low doses. This makes knowing **what is the medication classification of selegiline?** essential for comprehending its multifaceted clinical applications in both neurological and psychiatric contexts.